Eton Pharmaceuticals Stock Jumps 38% as Guidance Reset Tests Valuation
Eton Pharmaceuticals surged to a record on Friday. The rare-disease drugmaker paired a large sales beat with higher annual guidance. Shares traded at $56.40 at 11:19 EDT, up $15.60.
